Showing 15 posts of 15 posts found.


CEO of PixarBio Corporation sentenced to prison for defrauding investors

February 19, 2020
Research and Development Biopharmaceuticals, CEO, FDA, corruption, fraud, investors

Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in prison for defrauding investors and …

Teva settles $135 million dollar fraud case over Medicaid price inflation

January 14, 2019
Sales and Marketing court, fraud, law, lawsuit, pharma, price fxing

Israeli multinational Teva Pharmaceuticals has agreed to pay $135 million after being accused of fraudulently inflating wholesale prices that went …


Digital system may prevent £300m prescription fraud losses for NHS by 2020

October 15, 2018
Sales and Marketing NHS, fraud, government, prescription fraud, uk politics

The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …


Indian biotech owner detained in Dubai over £550m fraud allegations

August 16, 2018
Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …


Former Valeant executive and Philidor CEO charged with fraud

November 18, 2016
Medical Communications, Sales and Marketing Philidor, Valeant, Valeant Pharmaceuticals, fraud

Gary Tanner, former executive, and Andrew Davenport, ex-CEO of Philidor, have been arrested and charged with fraud. Preet Bharara, US …


Hard times continue for Valeant as ex-CEO investigated for fraud

November 1, 2016
Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud

Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …


Former shareholders sue Valeant, alleging “vast fraud”

August 19, 2016
Medical Communications, Sales and Marketing Valeant, fraud, lawsuit, t rowe price

Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …


Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud

April 28, 2016
Medical Communications, Sales and Marketing False Claims Act, Medicaid, Pfizer, US, Wyeth, department, fraud, insurer, justice

Pfizer has agreed to pay $784.6 million in a settlement with the US Department of Justice, relating to false and …


Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015
Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …


Allergan subsidiary president arrested on kickback charges

November 2, 2015
Sales and Marketing Allergan, US District Court, Warner Chilcott, fraud, healthcare fraud

Allergan subsidiary Warner Chilcott will plead guilty to a US felony charge of healthcare fraud, and settle a case of …

novartis image

Novartis faces data fraud charges in Japan

July 3, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan

Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …

Novartis back under microscope

June 23, 2014
Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines

Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …

Advair image

GSK ruling: Another failing, but will the industry learn?

July 4, 2012
Medical Communications, Sales and Marketing GSK, fraud, legal, marketing fine

Court papers surrounding GSK’s $3 billion fraud charge make for grim reading, and further damages an industry that already struggles …


GSK’s Stiefel accused of shares fraud

December 13, 2011
Sales and Marketing GSK, SEC, Stiefel, fraud

The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …

Latest content